The Consumer Healthcare market size was valued at USD 278 billion in 2022 and is expected to reach USD 492.12 billion by 2030 and grow at a CAGR of 7.4% over the forecast period of 2023-2030.
Consumer healthcare products are basically the products which are directly sold to the consumers. The driving factors which booms the Consumer healthcare products is the rise in the over-the-counter medicine, basically sometimes it’s not possible for every individual to go to the hospital due to the busy schedule and also due to the long process, so the over-the-counter medicines are the medicines given by the healthcare professional to the patient without any prescription, the consumer healthcare products mainly operates in oral, skin care and sometimes in nutrition’s as well. The restraining factor mostly includes the rules and regulation imposed by the government on the pharmaceuticals regarding the permission of selling the medicines without prescriptions mainly hinders the market. The development and launch in the online app based on the objective of fulfilling the consumer health product needs of the people is said to be the driving factor for the market in the future.
Covid 19 had an negative impact on the consumer healthcare products due to the strict rules imposed by the government, due to the less access for the people due to the lockdown the market had to face negative crisis which further got covered after the relaxation in the rules by the government, however the consumer healthcare products also include the basics and mandatory products which is used on daily basis like masks ,sanitizers etc which further raised the demand for the consumer healthcare products .
Drivers
Rise in the awareness of the over-the-counter medicines which is the driving factor for the healthcare consumer products.
The rise in the geriatric population and the need for self-medication in emergency cases.
In many nations around the world, the ageing population has been an important trend. Improvements in healthcare, better housing conditions, and longer life expectancies can all be credited with this rise. A growing number of older people require special treatment, including the ability to self-medicate in life-threatening situations. When people self-medicate, they take care of their own medical concerns without consulting a doctor. Utilising over-the-counter (OTC) drugs, natural cures, or other non-prescription treatments are all examples of this. Self-medication is acceptable for some minor illnesses, but it should always be done carefully, especially among the elderly.
Restrain
The stringent regulatory rules for the healthcare industry.
The lack of awareness among the people in the emerging countries.
Opportunity
Online consultancy and the rise in the awareness of the online pharmacies.
The increase in the launch of new apps related to the consumer health products.
Many consumer health applications concentrate on tracking and monitoring various elements of health, including physical activity, sleep patterns, heart rate, calorie intake, and more. To give real-time data and tailored insights, these apps frequently interact with wearable gadgets like activity trackers or smartwatches. Effective medication management is made possible by some apps. They can maintain medication schedules, remind people to take their medications, and even provide details on any drug interactions or negative side effects. People with complex prescription regimes or chronic diseases may find these apps to be very helpful.
Challenges
Changes in the perception of people regarding the over the counter and the online pharmacies.
The Russia Ukraine war will have an impact on the consumer healthcare market mostly in the areas affected by the war due to the supply and demand problems due to the disruption of routes also the loss of infrastructure of hospitals in the war and the loss of inventories, Also the factors like rise in the casualties and the medicines for them resulted in lack of medicines, painkillers, basic medicines had a negative impact on the consumer healthcare products.
Impact of ongoing recession
Consumer healthcare market will not be impacted on a great extent due to the factors which include the rise in the healthcare expense which will give a boom to the over-the-counter medicines worldwide also the change in the decision making of the consumers regarding switching towards the inexpensive products will contribute toward the consumer healthcare products. It has been reported on the basis of data the private labelled brands grow at a particular pace during the recession. Also, there will be a switch in the perception of people regarding the Rx and Toc which will also be growth contributing factor.
Market segmentation analysis
The consumer healthcare market is been divided into two segments which include by product and by the distribution network. By product include the OTC pharmaceuticals and the dietary supplements, The distribution network mostly includes the hypermarkets and supermarkets also the development in the new apps for the online service of providing the medicines to the consumers which is the considered as the important factor for the consumer healthcare products in the future.
By Product
OTC pharmaceuticals
Dietary Supplements
By distribution Channel
Departmental Stores
Retailers
Online Pharmacies
Supermarkets and Hypermarkets.
.png)
North America is the fastest growing region for the consumer healthcare market due to the rise in the geriatric population in this region and the self-medication necessity due to the fear of getting prone to the disease in the hospitals .Also the adaptability of the over the counter culture in this region is the driving factor for the consumer healthcare products .Also the rise in the number of the online pharmaceuticals in this region due to the demand for the same because of the busy life style of the people in the cities of North America is considered as the driving factor for the healthcare consumer market.
By Region
REGIONAL COVERAGE:
North America
USA
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Rest of Europe
Asia-Pacific
Japan
south Korea
China
India
Australia
Rest of Asia-Pacific
The Middle East & Africa
Israel
UAE
South Africa
Rest of Middle East & Africa
Latin America
Brazil
Argentina
Rest of Latin America
The major key players Pfizer, Abbott laboratories, Johnson & Johnson, Sanofi, Bayer Ag, Amway, BASF Se, GlaxoSmithKline, Teva Pharmaceuticals and Other Players
Abbott laboratories : The innovation of the new technology Biowearable the basic features of this technology is that it tracks the glucose, ketones , lactate.
Sanofi : Sanofi Ltd to unlock value with dedicated pharma and consumer healthcare business which will accelerate the growth of the consumer healthcare and pharma in India.
Bayer Ag : The company has developed a business unit which focuses on the precision health products and the range is mainly everyday health categories.
| Report Attributes | Details |
| Market Size in 2022 | US$ 278 Bn |
| Market Size by 2030 | US$ 492.12 Bn |
| CAGR | CAGR of 7.4% From 2023 to 2030 |
| Base Year | 2022 |
| Forecast Period | 2023-2030 |
| Historical Data | 2020-2021 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product (OTC Pharmaceuticals, Personal Care Products, Dietary Supplements) • By Distribution Channel (Online, Offline) |
| Regional Analysis/Coverage | North America (USA, Canada, Mexico), Europe (Germany, UK, France, Italy, Spain, Netherlands, Rest of Europe), Asia-Pacific (Japan, South Korea, China, India, Australia, Rest of Asia-Pacific), The Middle East & Africa (Israel, UAE, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
| Company Profiles | Pfizer, Abbott laboratories, Johnson & Johnson, Sanofi, Bayer Ag, Amway, BASF Se, GlaxoSmithKline, Teva Pharmaceuticals |
| Key Drivers | • Rise in the awareness of the over-the-counter medicines which is the driving factor for the healthcare consumer products. • The rise in the geriatric population and the need for self-medication in emergency cases. |
| Market Opportunities | • Online consultancy and the rise in the awareness of the online pharmacies. • The increase in the launch of new apps related to the consumer health products. |
Ans : The Consumer Healthcare market size was valued at USD 278 billion in 2022 and is expected to reach at USD 484 billion by 2030, and grow at a CAGR of 7.2% over the forecast period of 2023-2030.
Ans The major key players Pfizer, Abbott laboratories, Johnson & Johnson, Sanofi, Bayer Ag, Amway, BASF Se, GlaxoSmithKline, Teva Pharmaceuticals.
Ans: Covid-19 had a negative impact on the consumer healthcare products due to the strict rules imposed by the government.
Ans : North America region will dominate this market.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 COVID 19 Impact Analysis
4.2 Impact of the Ukraine- Russia war
4.3 Impact of ongoing Recession
4.3.1 Introduction
4.3.2 Impact on major economies
4.3.2.1 US
4.3.2.2 Canada
4.3.2.3 Germany
4.3.2.4 France
4.3.2.5 United Kingdom
4.3.2.6 China
4.3.2.7 Japan
4.3.2.8 South Korea
4.3.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Consumer Healthcare Market Segmentation, by Product
8.1 OTC Pharmaceuticals
8.2 Dietary Supplements
9. Consumer Healthcare Market Segmentation, by Distribution Channel
9.1 Departmental Stores
9.2 Retailers
9.3 Online Pharmacies
9.4 Supermarkets and hypermarkets
10. Regional Analysis
10.1 Introduction
10.2 North America
10.2.1 North America Consumer Healthcare Market by country
10.2.2North America Consumer Healthcare Market by Product
10.2.3 North America Consumer Healthcare Market by Distribution Channel
10.2.4 USA
10.2.4.1 USA Consumer Healthcare Market by Product
10.2.4.2 USA Consumer Healthcare Market by Distribution Channel
10.2.5 Canada
10.2.5.1 Canada Consumer Healthcare Market by Product
10.2.5.2 Canada Consumer Healthcare Market by Distribution Channel
10.2.6 Mexico
10.2.6.1 Mexico Consumer Healthcare Market by Product
10.2.6.2 Mexico Consumer Healthcare Market by Distribution Channel
10.3 Europe
10.3.1 Europe Consumer Healthcare Market by country
1.3.3.2 Europe Consumer Healthcare Market by Product
10.3.3 Europe Consumer Healthcare Market by Distribution Channel
10.3.4 Germany
10.3.4.1 Germany Consumer Healthcare Market by Product
10.3.4.2 Germany Consumer Healthcare Market by Distribution Channel
10.3.5 UK
10.3.5.1 UK Consumer Healthcare Market by Product
10.3.5.2 UK Consumer Healthcare Market by Distribution Channel
10.3.6 France
10.3.6.1 France Consumer Healthcare Market by Product
10.3.6.2 France Consumer Healthcare Market by Distribution Channel
10.3.7 Italy
10.3.7.1 Italy Consumer Healthcare Market by Product
10.3.7.2 Italy Consumer Healthcare Market by Distribution Channel
10.3.8 Spain
10.3.8.1 Spain Consumer Healthcare Market by Product
10.3.8.2 Spain Consumer Healthcare Market by Distribution Channel
10.3.9 The Netherlands
10.3.9.1 Netherlands Consumer Healthcare Market by Product
10.3.9.2 Netherlands Consumer Healthcare Market by Distribution Channel
10.3.10 Rest of Europe
10.3.10.1 Rest of Europe Consumer Healthcare Market by Product
10.3.10.2 Rest of Europe Consumer Healthcare Market by Distribution Channel
10.4 Asia-Pacific
10.4.1 Asia Pacific Consumer Healthcare Market by country
10.4.2 Asia Pacific Consumer Healthcare Market by Product
10.4.3 Asia Pacific Consumer Healthcare Market by Distribution Channel
10.4.4 Japan
10.4.4.1 Japan Consumer Healthcare Market by Product
10.4.4.2 Japan Consumer Healthcare Market by Distribution Channel
10.4.5 South Korea
10.4.5.1 South Korea Consumer Healthcare Market by Product
10.4.5.2 South Korea Consumer Healthcare Market by Distribution Channel
10.4.6 China
10.4.6.1 China Consumer Healthcare Market by Product
10.4.6.2 China Consumer Healthcare Market by Distribution Channel
10.4.7 India
10.4.7.1 India Consumer Healthcare Market by Product
10.4.7.2 India Consumer Healthcare Market by Distribution Channel
10.4.8 Australia
10.4.8.1 Australia Consumer Healthcare Market by Product
10.4.8.2 Australia Consumer Healthcare Market by Distribution Channel
10.4.9 Rest of Asia-Pacific
10.4.9.1 APAC Consumer Healthcare Market by Product
10.4.9.2 APAC Consumer Healthcare Market by Distribution Channel
10.5 The Middle East & Africa
10.5.1 The Middle East & Africa Consumer Healthcare Market by country
10.5.2 The Middle East & Africa Consumer Healthcare Market by Product
10.5.3 The Middle East & Africa Consumer Healthcare Market by Distribution Channel
10.5.4 Israel
10.5.4.1 Israel Consumer Healthcare Market by Product
10.5.4.2 Israel Consumer Healthcare Market by Distribution Channel
10.5.5 UAE
10.5.5.1 UAE Consumer Healthcare Market by Product
10.5.5.2 UAE Consumer Healthcare Market by Distribution Channel
10.5.6 South Africa
10.5.6.1 South Africa Consumer Healthcare Market by Product
10.5.6.2 South Africa Consumer Healthcare Market by Distribution Channel
10.5.7 Rest of Middle East & Africa
10.5.7.1 Rest of Middle East & Asia Consumer Healthcare Market by Product
10.5.7.2 Rest of Middle East & Asia Consumer Healthcare Market by Distribution Channel
10.6 Latin America
10.6.1 Latin America Consumer Healthcare Market by country
10.6.2 Latin America Consumer Healthcare Market by Product
10.6.3 Latin America Consumer Healthcare Market by Distribution Channel
10.6.4 Brazil
10.6.4.1 Brazil Consumer Healthcare Market by Product
10.6.4.2 Brazil Africa Consumer Healthcare Market by Distribution Channel
10.6.5 Argentina
10.6.5.1 Argentina Consumer Healthcare Market by Product
10.6.5.2 Argentina Consumer Healthcare Market by Distribution Channel
10.6.6 Rest of Latin America
10.6.6.1 Rest of Latin America Consumer Healthcare Market by Product
10.6.6.2 Rest of Latin America Consumer Healthcare Market by Distribution Channel
11. Company Profile
11.1 Pfizer
11.1.1 Market Overview
11.1.2 Financials
11.1.3 Product/Services/Offerings
11.1.4 SWOT Analysis
11.1.5 The SNS View
11.2 Abbott laboratories
11.2.1 Market Overview
11.2.2 Financials
11.2.3 Product/Services/Offerings
11.2.4 SWOT Analysis
11.2.5 The SNS View
11.3 Johnson & Johnson
11.3.1 Market Overview
11.3.2 Financials
11.3.3 Product/Services/Offerings
11.3.4 SWOT Analysis
11.3.5 The SNS View
11.4 Sanofi
11.4.1 Market Overview
11.4.2 Financials
11.4.3 Product/Services/Offerings
11.4.4 SWOT Analysis
11.4.5 The SNS View
11.5 , Bayer Ag
11.5.1 Market Overview
11.5.2 Financials
11.5.3 Product/Services/Offerings
11.5.4 SWOT Analysis
11.5.5 The SNS View
11.6 Amway
11.6.1 Market Overview
11.6.2 Financials
11.6.3 Product/Services/Offerings
11.6.4 SWOT Analysis
11.6.5 The SNS View
11.7 GlaxoSmithKline
11.7.1 Market Overview
11.7.2 Financials
11.7.3 Product/Services/Offerings
11.7.4 SWOT Analysis
11.7.5 The SNS View
11.8 BASF Se
11.8.1 Market Overview
11.8.2 Financials
11.8.3 Product/Services/Offerings
11.8.4 SWOT Analysis
11.8.5 The SNS View
11.9 Teva Pharmaceuticals
11.9.1 Market Overview
11.9.2 Financials
11.9.3 Product/Services/Offerings
11.9.4 SWOT Analysis
11.9.5 The SNS View
12. Competitive Landscape
12.1 Competitive Benchmarking
12.2 Market Share analysis
12.3 Recent Developmentsa
13. Used Cases & Best Practices
14. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Anesthesia Monitoring Devices Market Size was valued at USD 1.4 billion in 2023 and is expected to reach USD 2.2 billion by 2031 and grow at a CAGR of 6% over the forecast period 2024-2031.
The Smart Pills Market size was estimated USD 0.5 billion in 2022 and is expected to reach USD 1.2 billion by 2030 at a CAGR of 11.6% during the forecast period of 2023-2030.
The Cardiac Monitoring Devices Market size was valued at US$ 29.15 billion in 2023 and is projected to reach US$ 45.91 billion in 2031, with a growing CAGR of 5.84% during the forecast period 2024-2031.
The Healthcare Fraud Analytics Market Size was valued at USD 2.09 billion in 2022, and expected to reach USD 11.88 billion by 2030, and grow at a CAGR of 24.2% over the forecast period 2023-2030.
The Personalized Medicine Market size was estimated at USD 541.1 billion in 2022 and is expected to reach USD 933.19 billion by 2030 at a CAGR of 7.05% during the forecast period of 2023-2030.
The Microplate Reader Market size was estimated USD 488.8 million in 2023 and is expected to reach USD 904.74 million by 2031 at a CAGR of 8% during the forecast period of 2024-2031.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
